Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products.
Financial Results:
Marksans Pharma Ltd reported Revenues for Q1FY24 of ₹500.00 Crores up from ₹434.00 Crore year on year, a rise of 15.21%.
Total Expenses for Q1FY24 of ₹414.00 Crores up from ₹374.00 Crores year on year, a rise of 10.7%.
Consolidated Net Profit of ₹70.00 Crores up 16.67% from ₹60.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.52, up 4.11% from ₹1.46 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.